Form 4: MeiraGTx CEO Sells Shares Under 10b5-1 Plan

MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, sold 47,500 ordinary shares for a weighted average price of $8.39 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Alexandria Forbes, President & CEO and Director of MeiraGTx Holdings plc (MGTX), reported a sale of ordinary shares.
• The transaction involved the disposition of 47,500 ordinary shares on October 7, 2025.
• The shares were sold at a weighted average price of $8.39 per share.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Ms. Forbes on August 21, 2024.
• Following this transaction, Ms. Forbes directly beneficially owns 1,313,983 ordinary shares.
• The shares were sold in multiple transactions within a price range of $8.23 to $8.53.

Sentiment

Score: 5

Explanation: The transaction is a pre-scheduled sale under a 10b5-1 plan, which is generally considered a neutral event as it reflects personal financial planning rather than a reaction to new company-specific information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled liquidity event rather than a reaction to immediate negative news.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors, though its impact is mitigated by the pre-planned nature.

Future Outlook

This Form 4 filing reports a past insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction for MeiraGTx Holdings plc. Such transactions are common across all industries, including biotechnology, as executives manage personal finances and diversify portfolios. The pre-arranged nature of the sale under a 10b5-1 plan is a standard practice for managing insider trading compliance.

Stakeholder Impact

• Shareholders: May observe the insider sale, but the 10b5-1 plan context mitigates concerns about management's confidence.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.

Key Dates

Recommendation

The sale of shares by the President & CEO, Alexandria Forbes, was executed under a pre-arranged Rule 10b5-1 trading plan. Such plans are established in advance and are not typically indicative of management's immediate outlook on the company's prospects. Therefore, this transaction alone does not warrant a change in investment thesis, suggesting a 'hold' recommendation.

Keywords

MeiraGTx, MGTX, Alexandria Forbes, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Director, Biotechnology